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Correlation of Minimal Luminal Diameter and the
Decrease in Ischemic Response at Successive
Occlusions During PTCA
Advanced Age Does not Diminish the Results of
PTCA for Acute Ischemic Syndromes
Lesion # pts TECH ANGlO CLiN
LAD 23 57 (37, 77) 91 (79,100) 91 (79, 100)
RCA 30 63 (46, 80) 100 (88, 1DO) 100 (88, 100)
CIRC 22 82 (66, 98) 100 (85,1001 100 185, 100)
LMAIN 1 100 (2.5,1001 100 (25, 100) 100 (2.5, 100)
ALL 76 68 (58,781 97 (93,1001 97 (93,100)
TECH failures included: inability to cross &dilate in 01 pts, inability to toler-
ate 7-10 min dilatation in 16 pts, and use of autoperfusion balloon or stents
in 9 pts. CLiN failures included bypass in 2 pts (no Q-waves or deaths). Thus,
this pilot experience with PTCA of class C lesions using long duration, slow
oscillating inflation of long balloons suggests a randomized trial of "'ong
long" PTCA vs. more expensive techniques is warranted.
It is still matter of discussion, whether improved tolerance to ischemia at
successive balloon inflations (BI) reflects preconditioning or recruitment of
collaterals. The amount of collaterals in patients (pat) with stable angina de-
pends on the severity of the stenosis prior to PTCA. Therefore we studied the
ischemic response to serial BI in 21 patients (pat) with high-grade (>85%) (A)
in comparison to 16 pat with moderate stenoses of <70% (B). All pat had a
single vessel disease (LAD: n = 27; RCA: n = 10), normal ejection fraction
and no visible collaterals. PTCA consisted of 2 BI of 120 sec duration with
an interval of 5 minutes. Ischemia was assessed on chest pain {angina score
(ASI from 0-5), ST-elevation (mm), raise in pulmonary artery (PAP) (mmHgl
and drop in mean aortic pressure IMAP) ImmHg).
Results:
Advanced age has been recognized as adversely influencing the outcome
of coronary revascularization procedures. To determine the validity of this
relationship for patients (pts) with acute ischemic syndromes treated with
contemporary medical therapy, the outcomes of 444 pts who had PTCA per-
formed in TIMIIIIB were analyzed. Each pt received aspirin, heparin and an-
tianginal therapy.
with a target duration of 7-1 amin supported by Fluosol-DA (Alpha) perfusion.
Endpoints were: technical success (TECH): ability to reach, cross &dilate for
> 7 min; angiographic success (ANGlO): >20% reduction & <50% residual
stenosis; clinical success (CLlN): no Q-wave MI, bypass or death prior to
discharge. Results, as % (95% C.I.) were:
*p < 0.05, **p < 0.01 (baseline vs. 120 sec inflation)
Conclusion: The decrease in ischemia at successive 81 is dependent on
the severity of the stenosis. We conclude that this is due to recruitable collat-
erals and does not reflect ischemic preconditioning which would have been
expected to occur in all patients.
Luciano Pizzulli, Markus Zirbes, Wolfgang Fehske, Andreas Hagendorff,
Dietrich Pfeiffer, Berndt L0deritz. Department of Cardiology, University ofBonn Bonn,
Germany
1.BI 2.81
control 120 sec control 120 sec
A 1>90%)
PAP 15 ± 3 27 ± 6* 14 ± 4 19± 5
MAP 98 ± 12 94 ± 15 101 ± 9 95 ± 10
ST I 4.5 ± 2.2** I 2.4 ± 1.5*
AS 0 2.8 ± 0.6** 0 1.7±05*
B«70%1
PAP 16± 4 30 ± 4* 18 ± 5 31 ± 7*
MAP 94 ± 14 92 ± 16 95 ± 12 91 ± 8
ST I 5.5 ± 1.8** I 5.4 ± 2.2**
AS 0 3.9 ± 1.1** 0 4.0±1.1**
DaVid O. Williams, Bruce Thompson, Eugene Braunwald, Genell L. Knatterud,
Barry L. Sharat. Peter H. Stone. Rhode Island Hospital. Brown University, Providence,
Rhode Island
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Out-Patient Coronary Angioplasty is Safe and
Cost-Effective
Differential Sizing for Balloon Angloplasty:
Preliminary Results Using a New "Focal"
Balloon with an Expanding Central Section
William D. Knopf, Christopher U. Cates, Nicholas J. Lembo, Caryn Bernstein,
Robbie Moye. Atlanta CardiologV Group, Atlanta, GA
One of the major determinants of costs in healthcare is patient length of stay.
To determine if transluminal coronary angioplasty (TCA) can be performed
safely as an outpatient, 64 patients were randomized to a 9 hour stay (32) vs
an overnight stay (34). There was no statistical difference in the two groups
with regard to risk factors, age, previous TCA, CABG, MI or LVEF. Patients
in both groups had >80% class III or IV angina. There was no difference
in vessels dilated. 46 lesions were dilated in the inpatient group lip) vs 36
lesions in the outpatient group (op) (p = ns). Average balloons/lesion was
1.2 (ip) vs 1.2 (op) (p = ns).
There was no statistical difference in complications between the two
groups. One patient in the ip had acute closure resolved by coronary stent-
ing. However, this occurred prior to sheath removal.
All patients had follow-up at 24 hours and 7 days. One patient had suba-
cute closure 48 hours post procedure at home which resolved by redo TCA.
Patient satisfaction surveys indicate 94% patients and families prefer to go
home the same day as TCA despite an average distance to home of 83 miles.
Summary: Outpatient TCA can be performed safely in select patients with
high patient satisfaction, low patient complications and lower cost by reduc-
ing over all length of stay.
The majority of lesions treated by conventional balloon angioplasty (PTCA)
are focal and less than 10 mm in length. We sought to develop a balloon
which could deliver dilating force to the stenosis in a "focal" manner and
potentially decrease the chances of proximal and distal vessel dissection due
to overexpansion. The CAT balloon (CVD, Irvine, CAl uses variably compliant
material to maintain the proximal and distal 5 mm ends of the balloon at
a constant diameter while allowing the central 10 mm "focal" segment to
expand above nominal diameter at higher pressures. The additional central
diameter achievable is approximately 0.7 mm at 16 atm. A prototype 2.5 mm
(nominal) balloon was used in 30 lesions (23 pts). Success was achieved in all
but 1 case (no balloon would cross). In 3 cases, predilation with a <2.0 mm
balloon was required. In two lesions a larger balloon was subsequently used.
Quantitative analysis was available for 15 lesions. Diameter stenosis was
reduced from 65 ± 15% to 23 ± 14%. There was one type A dissection and
no complications. Initial inflation pressures averaged 6.0 ± 1.4 atm and final
pressures 11.3 ± 2.7 atm. QCA measured balloon diameters over a range of
pressures from 3 to 16 atm showed progressive relative enlargement of the
center section with increased pressures Ir = 0.521. At pressures <10 atm the
balloon center was 0.11 mm (5.6%1 larger than the ends while at pressures
~ 10 atm, the center was 0.44 mm 120.8%) larger (range 0.06 to 0.96 mm).
Conclusion: In this pilot series, the CATfocal balloon with a central expand-
ing section was effectively used to dilate coronary lesions without complica-
tions and with a high success rate. A randomized trial is planned to determine
if this design has advantages over standard balloon catheters.
82% at 4 Atm. In the wire facilitated angioplasty group the final diameter
stenosis was 21 % vs. 29% in the control group (p = 0.001) with a device ef-
ficiency IEFFI (final minimal lumen diameter + maximum balloon size) of 0.76
vs. 0.60 for the controls (p = 0.005). Conclusion: The use of a guidewire ex-
ternal to the balloon increases pressure transmitted to the lesion, improves
distensibility and lowers lesion yielding pressure. Longitudinal force focused
PTCA has the potential to improve acute lumen dimensions, prevent spiral
dissections and enhance device efficiency.
The "Long Long" Balloon Pilot: Dilatation of
Class C Coronary Lesions Using Slow,
Oscillating, Prolonged Inflation of 40 mm
Balloons
Mitchell W. Krucoff, Theodore L. Schreiber, Russell E. Raymond, Suzanne
W. Crater, Cindy L. Grines, Patrick L. Whitlow, Paul A. Gurbel, Donald F. Fortin,
William R. Herzog, Brian H. Annex, Cindy L. Green, Jack T. Cusma, Kenneth
G. Morris. Durham VA Medical Center, Durham, NC
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Revascularization of class C coronary lesions with expensive technologies
or surgery is based on poor acute results using 20 mm balloons. Longer bal-
loons and prolonged, slow oscillating inflations might reduce shear forces. To
test this, PTCA of class C lesions was attempted in 76 pts. using 40 mm Co-
bra POC8 (Scimed) balloons inflated with oscillation increasing 1-2 atm/min,
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Conclusions: (1) The Localmed Infusion Sleeve enables drug infusion to
be uncoupled from balloon dilatation. (2) Successful delivery of Urokinase
to the vessel wall may be achieved using this device without the need for
catheter exchange. 13} Persistence of urokinase within the vessel wall occurs
after local delivery.
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Local Delivery of Urokinase to Porcine Coronary
Arteries Using the Localmed infusion Sleeve
Michael A. Azrin, Joseph F. Mitchel, Laurine M. Bow, Tod V Alberghini,
Gordon Grant, Aaron V Kaplan, David D. Waters, Raymond G. McKay. Hartford
Hospital, Hartford, CT; University of Connecb'cut, Farmington, CT
this device, 1231-urokinase was delivered to 19 coronary arteries in 10 anes-
thetized pigs. All vessels underwent dilation at 6 atm, with simultaneous in-
fusion of urokinase. Drug was infused at an inflation pressure of 2 or 4 atm,
a balloon:artery ratio of either 1:1 or 1.2:1. and at a concentration of either
5,500 or 11,000 units/ml. Treated vessels were harvested up to 5 hrs later to
quantitate intramural drug deposition and washout.
Results: Successful drug delivery was accomplished in all vessels without
adverse hemodynamic, electrical, or angiographic sequelae. The efficiency
of drug delivery (i.e., % of delivered drug that was intramurally deposited)
ranged from 0.06 to 0.4%. Drug infusion pressure had no significant effect on
drug deposition. Higher urokinase concentrations and a higher balloon :artery
ratio resulted in higher intramural drug levels (p < 0.01). Urokinase deposition
and washout is described below:
Conclusions: Urokinase can be safely delivered at coronary angioplasty
sites using the Channelled balloon. Intramural drug deposition is related to
the concentration of infused drug and balloon:artery ratio. Although signif-
icant washout occurs, urokinase persists for at least 5 hours following de-
livery. This technique may be useful in the local dissolution of intracoronary
thrombus and creates a reservoir of urokinase at an angioplasty site which
may result in prolonged local thrombolysis.
Local Delivery of thrombolytic agents may reduce thrombus formation after
balloon angioplasty. The Localmed Infusion Sleeve enables localized infusion
of urokinase to be performed at the time of balloon angioplasty without the
need for catheter exchange. Methods: Balloon angioplasty was performed
on 13 coronary arteries of 5 pigs at 4 atmospheres with a balloon to artery
ratio of approximately 1.1 to 1. After angioplasty the Infusion Sleeve was
advanced over the dilatation balloon and the balloon was reinflated to 2 at-
mospheres to appose the sleeve to the vessel wall. 50,000 Units (8 ccl of
1231-urokinase was infused through the microperforations in the sleeve for
10 seconds by a computer controlled pump. The coronaries were then ex-
cised and counted in a gamma counter.
Results:
Paul A. Gurbel, Frank 1. NaveUa, Brent Muhlstein, Alan N. Tenaglia, David W. MUller,
Eric R. Bates, Charles J. Davidson, Michael J. Miller, Frank V Aquirre, James
B. Hermiller, Carl Tommaso, Lisa Berdan, Paul Owens, Glenn J. Beauman, Jeffrey
D. Lelmberger, Edwin BOVill, E. Magnus Ohman. University of Maryland, Baltimore,
MD: Duke University Medical Center, Durham, NC
PTCA in the setting of unstable angina (UA) and coronary thrombus (CT) is as-
sociated with adverse outcomes. We performed a pilot study of intralesional
tPA (20 mg) using an end-hole infusion (Tracker) catheter and intracoronary
heparin 15,000 units). delivered over 20 mins, prior to PTCA in 53 pts with
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Exercise Performance Predicts Long-term
Prognosis in Patients with PTCA for Multivessel
Disease
# Kaplan-Meier, 'p = 0.0000 by log-rank test
Age >= 65 (N = 154) Age < 651N ~ 290) p-value
% Imean) % (mean)
Age (years) 169.7) (53.91 0000
Male Gender 51.9 73.8 0000
Never Smoked 39.0 266 0.007
Prior MI 35.7 328 0.531
Hypertension 46.7 355 0.023
Non-O-Wave MI 31.4 403 0.063
Abnormal ECG 92.9 94.1 0597
LV EF (613) (58.7) 0038
2-3 Vessel Disease 50.0 36.0 0005
Angiographic Success 95.5 96.4 0.689
Events by 42 days
Death 1.3 14 0.938
MI 6.5 55 0.671
Stroke 0.0 0.3 0463
CABG 1.3 4.2 0.102
Death/MllStroke/CABG 8.4 9.0 0864
patients, n
8 yr survival#, %
8 yr surv. without MI or CABG#, %
In comparison to younger pts., elderly pts having PTCA in TIMIIIIB were
more often female, had not smoked, had history of hypertension and had
multivessel coronary disease. The results of PTCA were equally excellent in
both groups. Thus, advanced age alone does not adversely affect the results
of PTCA in selected pts with acute ischemic syndromes.
Christoph Kadel, Andrea Wolf, Rainer Schrader. University Hospital Frankfurt am
Main FRG
The aim of the study was to evaluate whether exercise performance
(watts*minl close to the time of PTCA predicts long-term prognosis in P with
multivessel disease (MVD). 1031 (study group) of 1252 consecutive P with
MVD and PTCA during 1977-90 underwent an exercise ECG. Exercise was
performed with a constantly maintained workload and terminated at severe
angina, ST.j, ;::3 mm, or at 6 min. Completeness of revascularization was
established by reangiograms in 564n96 successful P. Long-term follow-up,
ascertained by questionnaire in 97.9%, ranged from 2-15 (median 4.8) yrs.
Results. Univariate analyses revealed a strong correlation between exer-
cise performance and long-term prognosis:
Cox's multivariate regression determined exercise performance as the
most important predictor of long-term survival, p = 0.0000, followed by 3VD,
P = 0.001, and age, p = 0.01. Survival without MI or CABG was predicted
by completeness of revascularization, exercise performance, and acute suc-
cess, each p = 0.0000, and by 3VD, P = 0.02.
Conclusion. The functional parameter of exercise performance was a more
powerful predictor of long-term survival after PTCA in P with MVD than angio-
graphic parameters such as 3VD or completeness of revascularization and
therefore should be considered, if algorithms for estimation of long-term
outcome are designed.
The Channelled Balloon is a new local drug delivery catheter which allows for
simultaneous vessel dilation and local drug infusion at low pressure. In or-
der to assess the pharmacokinetics of intracoronary urokinase delivery with
1 1001-231 Localized Intracoronary Delivery of Urokinase
with the Channelled Balloon: Pharmacokinetics
of Drug Delivery and Washout
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